<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04737473</url>
  </required_header>
  <id_info>
    <org_study_id>UY1</org_study_id>
    <nct_id>NCT04737473</nct_id>
  </id_info>
  <brief_title>The Comparative Efficacy and Safety of Two General Anesthesia Protocols Consisting of Fentanyl Plus Propofol Plus Rococuronium Plus Isoflurane Versus Ketamime Plus Magnesium Sulphate Plus Lidocaine Plus Clonidine Plus Propofol Plus Rococuronium Plus Isoflurane for Gynaecology Surgery in Cameroon</brief_title>
  <acronym>OFA-AFRO</acronym>
  <official_title>General Anesthesia Usiing Fentanyl Plus Propofol Plus Rococuronium Plus Isoflurane Versus Ketamime Plus Magnesium Sulphate Plus Lidocaine Plus Clonidine Plus Propofol Plus Rococuronium Plus Isoflurane in Gynaecology Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Yaounde 1</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Yaounde 1</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recently, a lot of side effects have been identified from the perioperative use of opioids.&#xD;
      To remedy this, anesthesia research has recently focused on providing safe general anesthesia&#xD;
      without opioids in a new concept or anesthetic technic called Opiod Free Anesthesia (OFA).&#xD;
      Evidence on the effectiveness and safety of OFA is scarce in Africa, with no report from&#xD;
      Cameroon.The aim of this study is to demonstrate the feasibility of an adapted OFA protocol&#xD;
      as well as its efficacy and safety in very painful surgeries like gynaecology surgery in a&#xD;
      low-resource setting.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators intend to conduct a single-blinded randomized controlled trial on American&#xD;
      Society of Anesthesiologists (ASA) I and II women who will undergo elective myomectomy,&#xD;
      hysterectomy, ovarian cystectomy and mastectomy between June 2021 to September 2021 at the&#xD;
      Yaounde Gynaeco-Obstetric and Pediatric Hospital of Cameroon. Participants will be matched&#xD;
      for age and parity in a ratio of 1:1 into an Opiod Free Anesthesia (OFA) group and a general&#xD;
      anesthesia (GA) group. The primary endpoints shall be the success rate of OFA. The secondary&#xD;
      endpoints shall be the mumber or frequency of postoperative complications like respiratory&#xD;
      distress, nausea and vomiting, paralitic ileus and severe postoperative pain. The threshold&#xD;
      for statistical significance will be set at 0.05.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 6, 2020</start_date>
  <completion_date type="Anticipated">December 5, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative variables</measure>
    <time_frame>9 months</time_frame>
    <description>The success rate of OFA (defined as no intraoperative administration of opioids).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative variables</measure>
    <time_frame>9 months</time_frame>
    <description>The number of postoperative complications in the OFA and GA group. The complications to be determined will be the bumber of occurrence of severe postoperative pain, nausea and vomiting, respiratory distress and paralytic ileus</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Opioids</condition>
  <condition>Clinical Trial</condition>
  <condition>Anesthesia</condition>
  <condition>Gynecology</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Opiod Free Anesthesia (OFA) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The OFA protocol will entailed induction of anesthesia intravenously by the administration of the following drugs: magnesium sulfate 40mg/kg (without exceeding 2.5g), lidocaine 1.5mg/kg, ketamine 25mg, propofol 1.5-2mg/kg, dexamethasone 8mg and rocuronium 0.6mg/kg. Anesthesia will be maintained using isofluorane through volume controlled ventilation, and a mixture of magnesium sulfate 40mg/kg (without exceeding 2.5g/24h), lidocaine 1.5mg/kg, ketamine 25mg, and clonidine 1ug/kg in an electric pump syringe at 10 - 15 ml/h.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General anesthesia (GA) group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The GA protocol described in the intervention arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Opiod Free Anesthesia</intervention_name>
    <description>The OFA protocol will entailed induction of anesthesia intravenously by the administration of the following drugs: magnesium sulfate 40mg/kg (without exceeding 2.5g), lidocaine 1.5mg/kg, ketamine 25mg, propofol 1.5-2mg/kg, dexamethasone 8mg and rocuronium</description>
    <arm_group_label>General anesthesia (GA) group</arm_group_label>
    <arm_group_label>Opiod Free Anesthesia (OFA) group</arm_group_label>
    <other_name>General anesthesia (GA)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria :&#xD;
&#xD;
          -  American Society of Anesthesiology (ASA) grade I and II patients&#xD;
&#xD;
          -  Patients undergoing an elective myomectomy, hysterectomy, ovarian cystectomy or total&#xD;
             mastectomy.&#xD;
&#xD;
          -  Patients who will be operated for benign pathologies or localized malignancies&#xD;
&#xD;
        Exclusion Criteria :&#xD;
&#xD;
          -  Past history of allergy to any of the anesthetic drugs&#xD;
&#xD;
          -  Refusal to consent to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Females aged between 21 to 70 years old</gender_description>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacqueline Ze Minkande, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Yaounde I</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joel Noutakdie Tochie, MD</last_name>
    <phone>+237 676558825</phone>
    <email>joeltchie@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Yaounde Gynaeco-Obstetric and Pediatric Hospital</name>
      <address>
        <city>Yaound√©</city>
        <state>Centre</state>
        <zip>237</zip>
        <country>Cameroon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joel Noutakdie Tochie, MD</last_name>
      <phone>+237 676558825</phone>
      <email>joeltochie@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jacqueline Ze Minkande, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Roddy Stephane Bengono Bengono, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Junette Arlette Mbengono Metogo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raymond Ndikontar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacqueline Ze Minkande, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Cameroon</country>
  </location_countries>
  <results_reference>
    <citation>Guinot PG, Spitz A, Berthoud V, Ellouze O, Missaoui A, Constandache T, Grosjean S, Radhouani M, Anciaux JB, Parthiot JP, Merle JP, Nowobilski N, Nguyen M, Bouhemad B. Effect of opioid-free anaesthesia on post-operative period in cardiac surgery: a retrospective matched case-control study. BMC Anesthesiol. 2019 Jul 31;19(1):136. doi: 10.1186/s12871-019-0802-y.</citation>
    <PMID>31366330</PMID>
  </results_reference>
  <results_reference>
    <citation>Frauenknecht J, Kirkham KR, Jacot-Guillarmod A, Albrecht E. Analgesic impact of intra-operative opioids vs. opioid-free anaesthesia: a systematic review and meta-analysis. Anaesthesia. 2019 May;74(5):651-662. doi: 10.1111/anae.14582. Epub 2019 Feb 25.</citation>
    <PMID>30802933</PMID>
  </results_reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 3, 2021</study_first_submitted>
  <study_first_submitted_qc>January 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 3, 2021</study_first_posted>
  <last_update_submitted>January 31, 2021</last_update_submitted>
  <last_update_submitted_qc>January 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Yaounde 1</investigator_affiliation>
    <investigator_full_name>Joel Noutakdie Tochie</investigator_full_name>
    <investigator_title>Medical Doctor/Anesthetist</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

